Maxim Group Downgrades Blue Water Biotech to Hold
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Jason McCarthy has downgraded Blue Water Biotech (NASDAQ:BWV) from Buy to Hold.
September 13, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Blue Water Biotech has been downgraded from Buy to Hold by Maxim Group, which could potentially impact the stock's performance.
Analyst ratings often influence the market's perception of a stock. A downgrade from Buy to Hold suggests that the analyst sees less upside potential, which could lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100